| Lloyd Kelsey Armstrong, DPM | |
|
2511 Old Cornwallis Rd, Suite 200, Durham, NC 27713-1869 | |
| (919) 932-5700 | |
| (919) 933-6881 |
| Full Name | Lloyd Kelsey Armstrong |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 2511 Old Cornwallis Rd, Durham, North Carolina |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154384980 | NPI | - | NPPES |
| 5902531 | Medicaid | NC | |
| 8521364 | Other | CIGNA HEALTHCARE | |
| P00288880 | Other | RAILROAD MEDICARE | |
| 2531375 | Other | UNITED HEALTHCARE | |
| E4262 | Other | NC | MEDCOST |
| Provider Name | Armstrong Podiatry & Sports Health, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518165661 PECOS PAC ID: 2264519719 Enrollment ID: O20080408000317 |
News Archive
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
Cleveland Clinic researchers have identified a gut microbe generated byproduct - phenylacetylglutamine - that is linked to development of cardiovascular disease, including heart attack, stroke and death.
› Verified 2 days ago
| Provider Name | Doctors Making Housecalls Geriatric Medicine Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558501353 PECOS PAC ID: 5799837696 Enrollment ID: O20090806000708 |
News Archive
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
Cleveland Clinic researchers have identified a gut microbe generated byproduct - phenylacetylglutamine - that is linked to development of cardiovascular disease, including heart attack, stroke and death.
› Verified 2 days ago
| Provider Name | Eventus Wholehealth Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548759392 PECOS PAC ID: 6002169539 Enrollment ID: O20181030001281 |
News Archive
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
Cleveland Clinic researchers have identified a gut microbe generated byproduct - phenylacetylglutamine - that is linked to development of cardiovascular disease, including heart attack, stroke and death.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lloyd Kelsey Armstrong, DPM 2511 Old Cornwallis Rd, Suite 200, Durham, NC 27713-1869 Ph: (919) 932-5700 | Lloyd Kelsey Armstrong, DPM 2511 Old Cornwallis Rd, Suite 200, Durham, NC 27713-1869 Ph: (919) 932-5700 |
News Archive
Following a kick-off meeting, the TransLUMINAL-B project, which is being led by Charité - Universitätsmedizin Berlin, is now officially underway. Over the next three years, researchers involved in the project will study the process of metastasis formation and the role of malignant cells, which accumulate in the blood and bone marrow of patients with certain types of breast cancer.
The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
Cleveland Clinic researchers have identified a gut microbe generated byproduct - phenylacetylglutamine - that is linked to development of cardiovascular disease, including heart attack, stroke and death.
› Verified 2 days ago